How eHave is Quietly Building a Leading EHR Platform
Ryan Allway
October 27th, 2021
Psychedelics, Top News
The medical software industry is ripe for innovation. Unfortunately, many providers still use paper forms or outdated EHR platforms to manage patient billing and health records. The good news is that newer EHR platforms are popping up to address critical shortcomings, particularly in niche markets where conventional EHR platforms don’t fit the bill.
Let’s look at EHR challenges facing the mental health profession and how Ehave Inc. (OTC: EHVVF) aims to overcome them with its innovative EHR platform.
Also: Download the company’s investor presentation and receive corporate updates.
Why EHRs Matter
Data sharing is a common frustration among health care providers given strict patient confidentiality laws and many points of contact.
Electronic health records, or EHRs, are digital versions of a patient’s paper chart. While these records contain medical and treatment histories, they typically go beyond standard clinical data to provide a broad view of a patient’s care. The goal is to automate and streamline provider workflow while making it easy to access information to support medical decisions.
Unfortunately, most EHRs aren’t built for mental health patients and providers. For example, therapists often record sessions or take notes, and most EHRs don’t provide an easy way to search these notes. At the same time, psychedelics and other emerging mental health treatments may not fit neatly into conventional health records.
Ehave’s Dashboard
Ehave built an extensible EHR platform to address these issues with powerful, condition-specific applications.
Like most EHR platforms, Ehave Dashboard is HIPAA compliant, but it goes beyond compliance to provide other key data advantages. For example, the platform leverages blockchain technology to create highly secure and immutable health records that are easy to access, share, and e-sign with transparent tracking along the way.
The platform also makes it easy to search medical records, including video and audio transcripts, using natural language processing—or NLP. Using machine learning algorithms, NLP can isolate the most common keywords, detect the main topics, collect prescription medications, and make it easy to search these data points via text input.
Building an Ecosystem
Ehave’s EHR platform fits hand-in-hand with its other innovative software tools to improve mental health diagnostics and treatments.
Also see: Ehave Looks to Power the Psychedelics Revolution
The company partnered with Vastminz to develop an AI-powered computer vision technology capable of identifying physiological conditions, such as heart rate, heart rate variability, respiration rate, oxygen saturation, and other vital statistics via a mobile phone. These capabilities could help patients report more data from their homes.
In addition, the company signed a letter of intent to acquire Moksha Digital, a medical imaging software provider with seven major hospitals as clients. The move could add medical image sharing capabilities and other reports to its EHR system to bolster its potential further. The seven significant clients could also become users of its EHR platform.
Looking Ahead
Ehave Inc.’s (OTC: EHVVF) EHR platform provides critical solutions for mental health providers and patients. However, the company’s software business represents just one of its many areas of focus. For instance, the company’s KetaDASH platform partners with existing ketamine clinics to provide DoorDash-like services for mental health patients.
Don’t forget: Download the company’s investor presentation and receive corporate updates.
The company also hired a contract research organization, or CRO, to design clinical trials and start collecting certain data points to understand how ketamine can potentially resolve issues in the brain through a process known as neuroplasticity. These kinds of clinical trials could be managed with its dashboard and telemetry tools.
Investors may want to keep an eye on Ehave as it continues to build out its EHR platform and integrate it with other areas of its business. For instance, KetaDASH’s network of ketamine clinics could be a key end market for its innovative EHR platform. These kinds of cross-selling opportunities could unlock a lot of long-term synergies.
For more information, visit the company’s website or download their investor presentation.
Disclaimer
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
MichiCann Medical Inc. owns or controls 11 medical cannabis dispensaries in Michigan and is in the final stages to acquire another 11 shops, as well as three indoor cultivation facilities in the state.
3Sixty is one of Canada’s leading security service providers to the cannabis sector.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
